Kidney Transplant Rejection – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Kidney Transplant Rejection – Drugs In Development, 2024 report and make more profitable business decisions.
Kidney transplantation is a therapy performed to replace a diseased kidney with a healthy kidney from another person. Risk factors associated with transplantation are bleeding, infection, blockage of the blood vessels to the new kidney, leakage of urine or blockage of urine in the ureter, and initial lack of function of the new kidney. Treatment includes immunosuppressive drugs to prevent organ rejection.
The Kidney Transplant Rejection drugs in development market research report provide comprehensive information on the therapeutics under development for Kidney Transplant Rejection, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Kidney Transplant Rejection and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Kidney Transplant Rejection | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 51 molecules, with 47 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Kidney Transplant Rejection therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Kidney Transplant Rejection pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Kidney Transplant Rejection treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Alphamab OncologyAltruBio Inc
Amgen Inc
Amyndas Pharmaceuticals LLC
Astellas Pharma Inc
Bristol-Myers Squibb Co
Conduit Pharmaceuticals Inc
Cynata Therapeutics Ltd
Eledon Pharmaceuticals Inc
Enceladus Pharmaceuticals BV
Guard Therapeutics International AB
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Hansa Biopharma AB
Heidelberg University Hospital
Helmholtz Center Munich German Research Center for Health and Environment GmbH
Helocyte Biosciences Inc
Hillhurst Biopharmaceuticals Inc
Horizon Therapeutics Plc
ITB-Med AB
Jiangsu Hengrui Medicine Co Ltd
JN Biosciences LLC
Junten Bio Co Ltd
Lignamed LLC
Lyndra Therapeutics Inc.
Medeor Therapeutics Inc
MyeloRx LLC
Nekonal Sarl
NovelMed Therapeutics Inc
Paranta Biosciences Ltd
Rigel Pharmaceuticals Inc
Sangamo Therapeutics Inc
Suzhou Regend Therapeutics Co Ltd
SYnAbs SA
TolerogenixX GmbH
Tonix Pharmaceuticals Holding Corp
Tourmaline Sub Inc
Trained Therapeutix Discovery Inc
University of Pennsylvania
University of Regensburg
Veloxis Pharmaceuticals Inc
Xenothera SAS
Zenas BioPharma (USA) LLC
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Kidney Transplant Rejection reports